Drug intelligence / Profile preview

Blink Triple Care

Development stage: Unknown
Lead developer: Bausch + Lomb
Modality: Small Molecules
Administration: Ophthalmic

Overview

**Blink Triple Care** is a Bausch & Lomb over-the-counter ophthalmic lubricating eye-drop formulation for temporary relief of burning, irritation, and discomfort associated with ocular dryness. Its sole labeled active ingredient is **polyethylene glycol 400 0.25%**, a hydrophilic polymer lubricant that improves ocular-surface lubrication and hydration. The formulation also contains sodium hyaluronate and lipid-associated inactive ingredients including castor oil and polyoxyl 40 hydrogenated castor oil, intended to support tear-film hydration and reduce moisture evaporation. It is marketed for moderate-to-severe dry-eye symptoms and is administered as ophthalmic drops.

Brand names: Blink Triple Care
Other names: BTC

Beyond the preview

Go deeper on Blink Triple Care.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blink Triple Care.

Explore the full profile